CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...
A ruthenium catalyst facilitated the polymerization, or polymer addition. Industrial firms have used this catalyst to make ...
The new Express License service removes barriers to accessing this transformative gene editing technology for startups.An ...
CRISPR-Cas9 is one of the biggest discoveries of the 21st century. Since it was developed in 2012, this gene-editing tool has revolutionized biology research, making it easier to study disease and ...
In this installment, we delve into one of the most debated scientific advancements of our time: CRISPR gene-editing ...
CRISPR gene-editing technology presents a possible solution for feeding a growing population, but incorporating CRISPR into ...
Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal ...
ON CRISPR enzyme, will combine with RNA guides for pharma customers. Deal follows HuidaGene agreement, offers 99% cost ...
Finding out your dog’s breed can be a fun experience, but there are also plenty of reasons to get a dog DNA kit that will have an impact on your furry friend’s wellbeing. Identifying genetic ...
Synthego granted global license to manufacture and distribute AZ's CRISPR gene editing enzyme, eSpOT-ON.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback